智通财经APP讯，思派健康(00314)发布公告，于2025年12月18日，该公司斥资35.95万港元回购15.08万 股股份，每股回购价格为2.36-2.44港元。于同日，根据经修订及经重列2017年全球股份计划行使期权而 发行2000股股份。 ...

格隆汇12月18日丨思派健康(00314.HK)公告，12月18日耗资36万港元回购15万股。 ...

如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | | 證券代號 (如上市) | 00314 | 說明 | | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | 事件 | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | 每股發行/出售價 (註4) | | 已發行股份總數 | | | | 已發行股份（不包括庫存股份）數 目 | | 佔有關事件前的現有已發 行股份（不包括庫存股 份）數目百分比 (註3) | 庫存股份數目 | | | | | 於下列日期開始時的結存(註1) ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年11月30日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 思派健康科技有限公司 呈交日期: 2025年12月3日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00314 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 2,000,000,000 | USD | | 0.0001 | USD | | 200,000 | | 增加 / 減少 (-) | | | | | | | USD | | 0 | | 本月底結存 | | | 2,000,000,000 | USD | | 0.0001 | USD | | 200,000 | 本月底法定/註冊 ...

Core Viewpoint - Sipai Health (00314.HK) announced a share buyback of 263,000 shares at a cost of HKD 652,000 on November 5 [1] Summary by Category - **Company Actions** - The company executed a buyback of 263,000 shares, indicating a commitment to enhancing shareholder value [1] - The total expenditure for this buyback was HKD 652,000, reflecting the company's strategy to manage its capital effectively [1]

Core Viewpoint - Sipai Health (00314) announced a share buyback plan, indicating a strategic move to enhance shareholder value through the repurchase of shares [1] Group 1 - The company will spend approximately HKD 651,900 to repurchase 263,200 shares [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 思派健康科技有限公司 呈交日期： 2025年11月5日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 00314 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | 每股發行/出售價 (註4) | 已發行股份總數 | | 事件 | | 已發行 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年10月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 思派健康科技有限公司 呈交日期: 2025年11月5日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00314 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 2,000,000,000 | USD | | 0.0001 | USD | | 200,000 | | 增加 / 減少 (-) | | | | | | | USD | | 0 | | 本月底結存 | | | 2,000,000,000 | USD | | 0.0001 | USD | | 200,000 | 本月底法定/註冊 ...

[Supplemental Announcement Overview](index=1&type=section&id=Supplemental%20Announcement%20Overview) This section provides an overview of the supplemental announcement, detailing its purpose and scope [Purpose and Scope of Announcement](index=1&type=section&id=Purpose%20and%20Scope%20of%20Announcement) This announcement supplements the 2024 annual report of Spai Health Technology Co., Ltd., providing additional information on the company's share schemes - This announcement supplements the 2024 annual report, primarily providing additional information on the company's share schemes (2017 Scheme, Restricted Share Unit Scheme, and 2023 Share Award Scheme)[3](index=3&type=chunk)[9](index=9&type=chunk) - All other information in the annual report remains unchanged[9](index=9&type=chunk) [Details of Share Scheme Updates](index=1&type=section&id=Details%20of%20Share%20Scheme%20Updates) This section provides updated details on the company's 2017 Scheme, Restricted Share Unit Scheme, and 2023 Share Award Scheme [2017 Scheme](index=1&type=section&id=2017%20Scheme) The 2017 Scheme's outstanding share options decreased between the annual report date and the announcement date, with a remaining term of approximately three years Outstanding Share Options Under 2017 Scheme | Grantee | Outstanding as of Annual Report Date (shares) | Approximate Percentage of Total Issued Shares (Annual Report Date) | Outstanding as of Announcement Date (shares) | Approximate Percentage of Total Issued Shares (Announcement Date) | | :--- | :--- | :--- | :--- | :--- | | Employees | 5,970,317 | 0.78% | 4,883,320 | 0.65% | | Service Providers | 804,900 | 0.11% | 733,900 | 0.10% | | Total | 6,775,217 | 0.89% | 5,617,220 | 0.75% | - As of the announcement date, the total outstanding share options under the 2017 Scheme decreased from **6,775,217** (0.89% of issued shares) on the annual report date to **5,617,220** (0.75% of issued shares)[4](index=4&type=chunk) - The 2017 Scheme commenced in January 2018 with a ten-year validity period, having approximately **three years** remaining as of the end of the reporting period[5](index=5&type=chunk) [Restricted Share Unit Scheme](index=2&type=section&id=Restricted%20Share%20Unit%20Scheme) The Restricted Share Unit Scheme had no outstanding units as of both dates and was resolved to be terminated early by the board due to all shares being vested Outstanding Restricted Share Units | Grantee | Outstanding as of Annual Report Date | Approximate Percentage of Total Issued Shares (Annual Report Date) | Outstanding as of Announcement Date | Approximate Percentage of Total Issued Shares (Announcement Date) | | :--- | :--- | :--- | :--- | :--- | | Zhou Teng | Nil | Nil | N/A | N/A | - As of both the annual report date and the announcement date, there were **no outstanding restricted share units** under Zhou Teng's name[6](index=6&type=chunk) - The Restricted Share Unit Scheme commenced in June 2021 with a ten-year validity period, having approximately **six years** remaining as of the end of the reporting period[7](index=7&type=chunk) - The Board resolved on **August 18, 2025**, to early terminate the Restricted Share Unit Scheme, as all relevant shares have been duly vested and the trustee holds no funds or property[7](index=7&type=chunk) [2023 Share Award Scheme](index=3&type=section&id=2023%20Share%20Award%20Scheme) The 2023 Share Award Scheme has a total cap of 8% of issued share capital, with 60,820,600 shares purchased by the trustee but none yet awarded - The total number of share awards under the 2023 Scheme is capped at **8%** of the company's issued share capital as of the adoption date (approximately **7.99%** as of the annual report date)[8](index=8&type=chunk) Share Purchases Under 2023 Scheme | Date | Total Shares Purchased (shares) | Approximate Percentage of Issued Share Capital (excluding treasury shares) | | :--- | :--- | :--- | | Annual Report Date | 42,297,400 | 5.56% | | Announcement Date | 60,820,600 | 8.10% | - As of the announcement date, the company has **not yet awarded any shares** under this scheme[8](index=8&type=chunk) - The 2023 Share Award Scheme commenced in August 2023 with a ten-year validity period, having approximately **eight years** remaining as of the end of the reporting period[9](index=9&type=chunk) [Other Information](index=3&type=section&id=Other%20Information) This section provides additional information, including the composition of the Board of Directors [Board of Directors Composition](index=3&type=section&id=Board%20of%20Directors%20Composition) The announcement is signed by Mr. Ma Xuguang, Chairman and Executive Director, and details the board's composition as of the announcement date - The announcement is signed by **Mr. Ma Xuguang**, Chairman and Executive Director of the Board[10](index=10&type=chunk) - As of the announcement date, the Board members include Executive Directors **Mr. Ma Xuguang** and **Mr. Li Ji**; Non-executive Director **Mr. Yao Leiwen**; and Independent Non-executive Directors **Mr. Fan Xin**, **Mr. He Haijian**, and **Ms. Huang Bei**[11](index=11&type=chunk)

Summary of Key Points Core Viewpoint - As of October 14, a total of 75 stocks reached their 52-week highs, with notable performances from Lihua Securities Holdings (08350), Deutsche Bank Tianxia (02418), and Chuangsheng Holdings (02680) [1]. 52-Week Highs - Lihua Securities Holdings (08350) achieved a closing price of 0.325, with a peak of 0.390, marking a high rate of 34.48% - Deutsche Bank Tianxia (02418) closed at 8.120, reaching a maximum of 8.990, with a high rate of 24.86% - Chuangsheng Holdings (02680) closed at 12.100, peaking at 12.350, with a high rate of 23.50% - Other notable stocks include Century United Holdings (01959) with a high rate of 20.97% and Silicon Xin Group (08349) with 14.38% [1]. 52-Week Lows - Hengda Group Holdings (03616) recorded a closing price of 0.345, with a low of 0.300, reflecting a decline rate of -11.76% - China Technology Industry Group (08111) reached a low of 0.085, with a decline rate of -8.89% - Other significant declines include Golden Leaf International Group (08549) at -8.06% and Changfeng Pharmaceutical (02652) at -4.90% [3].